Record #38985

MiR-22 inhibition alleviates cardiac dysfunction in doxorubicin-induced cardiomyopathy by targeting the sirt1/PGC-1α pathway

Citation lifecycle

How this paper is being cited

Pre-retraction
2
Same day
0
Post-retraction
6
% post-retraction
75.0%
~1.4 citations/yr before retraction · ~1.5 citations/yr after
citing papers

Who is still citing this work

Loading…